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Experimental Details
Peptide Fragmentation Nomenclature
Peptide fragmentation nomenclature used in this study for c- and z-type ions produced by ECD 
and ETD versus a- and x-type ions produced by FRIPS is explained in Figures S1 and S2. The 
nomenclature of peptide fragmentation was initially proposed by Roepstorff and Fohlman1, and 
Johnson et. al.2 In this work, we follow recent notations used for electron capture dissociation 
spectra, where z• ion is (z + 1) ion.
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Figure S1. Peptide fragmentation by β-hydrogen abstraction followed by β-cleavage. Formation 
of a and z• ions is the major pathway.
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Figure S2. Peptide fragmentation by β-hydrogen abstraction followed by β-cleavage. Neutral 
loss is the major pathway.
Materials. 
The model peptides, AARAAACAA, in 95% peptide purity, and AARAAACAA with a 
deuterated β-carbon at the cysteine residue, in 98% isotope purity, and 75% peptide purity, were 
purchased from Biomer Technology LLC (Pleasanton, CA, USA). Vasoactive intestinal peptide 
(VIP) from human, residue 1-12 (HSDAVFTDNYTR) that simulates tryptic peptides, and Arg8-
Vasopressin (CYFQNCPRG-NH2, Cys1 and Cys6 are connected via a disulfide bond) were 
purchased from AnaSpec (San Jose, CA, USA). Arg8-Conopressin G (CFIRNCPRG-NH2, Cys1 
and Cys6 are connected via a disulfide bond) was purchased from Bachem (Torrance, CA, USA). 
Bovine insulin was purchased from Sigma Aldrich (St. Louis, MO, USA). A soluble free radical 
initiator, Vazo 68, was purchased from DuPont (Wilmington, DE, USA). Acetic anhydride was 
purchased from Mallinckrodt Inc. (Phillpsburg, NJ, USA). All solvents are HPLC grades and 
were purchased from EMD Merck (Gibbstown, NJ, USA). Sequencing grade TPCK treated 
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trypin was purchased from Promega (Madison, WI, USA). All other chemicals were purchased 
from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise specified. For desalting, OMIX 100 
μL size C-18 tips were purchased from Varian Inc. (Palo Alto, CA, USA).
Synthesis of TEMPO-based FRIPS Reagent.
Synthesis strategy for the second generation TEMPO-based FRIPS reagent, 2,5-
dioxopyrrolidin-1-yl 2-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)acetate was published by Thomas 
et al.3 The previous development by Lee et al.4 was modified by replacing 2-
(bromomethyl)benzoic acid methyl ester with methyl 2-bromoacetate for the current study. 
Briefly, TEMPO is coupled to the acetyl methyl ester group, followed by deprotection and 
activation of the carboxylic acid group. Ten mg/mL of the final product, 2,5-dioxopyrrolidin-1-yl 
2-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)acetate in acetonitrile (ACN) was reacted with 50 μg 
of model peptides in 100 mM phosphate buffer (pH 8.5) for 2 hr. After desalting, the resulting 
peptide conjugates were analyzed by electrospray ionization (ESI) mass spectrometry. 
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For bioconjugation of the TEMPO-based FRIPS reagent, 10 µL of bovine insulin stock 0.33 
mM in DMSO (Note that bovine insulin is poorly soluble in distilled water at high 
concentration), 10 µL of TEMPO-FRIPS stock 10 µg/µL in acetonitrile (~32 mM, 100 eq.), and 
80 µL of 10 mM phosphate buffer saline, pH adjusted to 6.3 to avoid lysine modification and 
disulfide scrambling,5 were mixed and incubated at room temperature overnight with a constant 
vortexing at 200 rpm. The reaction mixture was desalted by HPLC using a C18 trap column 
(Microscience, CA) and the resulting eluent was freeze-dried by speedvac. The dried sample was 
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readjusted in 0.1% formic acid, 50% acetonitrile, and 50% water and directly infused into the 
electrospray source of the mass spectrometer.
Mass Spectrometry.
 AARAAACAA and VIP peptide FRIPS experiments were performed using a LCQ Deca XP 
ion trap mass spectrometer (Thermo, San Jose, CA, USA). Prepared peptide solutions were 
directly infused to the mass spectrometer at 3 μL/min by a syringe pump with an electrospray 
ionization source. Critical parameters of the mass spectrometer include spraying voltage 3.5 kV, 
capillary voltage 41~42 V, capillary temperature 275 °C, and tube lens voltage −50~60 V. Other 
ion optic parameters were optimized by the auto-tune function in the LCQ tune program for 
maximizing the signal intensity. The precursor isolation window for MSn experiments was set to 
3.5 m/z, and normalized collisional energy in the LCQ tune program was varied from 23% to 28% 
based on residual precursor ion intensities. For FRIPS and CID spectra, 100 scans were recorded.
ECD and high-resolution FRIPS experiments were performed in the Proteome Exploration 
Laboratory of the Beckman Institute at Caltech using a 7-tesla linear ion trap Fourier transform 
ion cyclotron resonance (LTQ-FTICR) mass spectrometer (Thermo, San Jose, CA, USA) 
equipped with the Nanomate (Advion BioSciences Inc., Ithaca, NY, USA) nanospray unit. The 
spraying voltage was 1.4 kV, and the gas pressure was 0.3 psi. Critical parameters of the mass 
spectrometer include capillary voltage 49 V, capillary temperature 200 °C, and tube lens voltage 
180 V. Other ion optic parameters were optimized by the auto-tune function in the LTQ tune 
program for maximizing the signal intensity. The target resolution at 400 m/z was set to 100,000. 
The precursor isolation window for ECD experiments was set to 5.0 m/z and electron irradiation 
occurred for 100ms at 5% of the full energy scale in the LTQ tune program, corresponding to 
electron energies less than approximately 1 eV. For ECD spectra, 100 scans were recorded. In 
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particular, the TEMPO-based FRIPS reagent conjugates of intermolecular disulfide bond 
containing peptides (2), Arg8-Conopressin G, and trypsin digested Arg8-Conopressin G were 
analyzed by ion trap scans in a hybrid LTQ-FTICR mass spectrometer with the nanospray and 
ion optics conditions described above.
An LTQ ion trap mass spectrometer (Thermo, San Jose, CA) was utilized for FRIPS analyses 
of insulin. The sample was infused directly to the commercial electrospray source at a flow rate 
of 1 µL/min. The following instrumental parameters were used: 5 kV spray voltage, 45 V 
capillary voltage, 125 V tube lens voltage, and 275 C° capillary temperature. The high-mass 
scanning mode (m/z up to 4000) was employed to monitor the singly charged insulin A-chain ion 
and other potential fragments.
Quantum Chemical Calculation.
Scheme S1
N,N'-diacetyl-cystine-N-methylamide (Scheme S1) was used for the simple model system to 
describe the intermolecular disulfide bond linked peptide used in this study, CH3CONH-
[AARAAACAA]-S-S-[AARAAACAA] (5). Initial geometries were generated by the MC/MM 
conformer search using Macromol 8.0 (Schrödinger Inc., Portland, OR, USA) as implemented in 
Maestro 8.0 (Schrödinger Inc., Portland, OR, USA) under the linux environment. The OPLS 
2005 was used for the force field model. Within 5 kcal/mol energy, all low energy conformers 
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were initially recorded. After manual screening of obtained structures to avoid redundancy, low 
energy conformers were selected for further structure optimization by density functional theory 
(DFT). For radical species, ad hoc assignment of the formal charge state was employed to 
implement MC/MM calculations for conformer searching. In particular, conformers of the Cβ 
hydrogen abstracted N,N'-diacetyl-cystine-N-methylamide radical were searched by substitution 
of the β-carbon with boron to simulate the trigonal bonding environment. Each conformer was 
subject to a geometry optimization using Jaguar 7.5 (Schrödinger Inc., Portland, OR, USA) at the 
B3LYP/6-31G(d) level. By monitoring the occurrence of imaginary vibrational frequencies, only 
non-transition state structures (i.e. no imaginary vibrational frequency) were further optimized 
using a higher basis set at the B3LYP/6-311++G(d,p) level. The transition state structures were 
searched using the LST or QST methods by interpolating initial guesses for reactants, products 
and transition states. Single point energy was refined using Q-Chem 3.1 (Q-Chem Inc., Pittsburg, 
PA, USA) by the BMK, M05-2X, M06-2X and B3LYP density functionals with the 6-
311++G(3df,3pd) basis set. The three new generation meta-hybrid functionals were chosen for 
their ability to more reliably predict the energetics of organic radical reactions.6 For the open-
shell systems, the spin-unrestricted method was used. All calculations were performed using 
computational resources kindly provided by the Material and Process simulation center at the 
Beckman Institute, Caltech.
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Figure S3. The CID spectrum (a) and FRIPS (MS3, Vazo 68 and the TEMPO-based reagent) 
spectra (b and c, respectively) of singly protonated HSDAVFTDNYTR. The CID spectrum (a) is 
dominated by y4 and y9 ions from the low energy salt bridge cleavage pathway at the C-terminal 
sides of aspartic acids, effected by the protonated arginine residue. This results in poor sequence 
coverage (6 out of 11 backbone cleavages observed, 55%). b) and c) are nearly identical, 
yielding mainly backbone cleavage fragments (10 out of 11 backbone cleavage observed, 91% 
sequence coverage) and neutral losses. Bold arrows indicate the precursor ions.
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Figure S4. FRIPS of AARAAACAA. a) and b) ESI-MS1 spectra of Vazo 68 and TEMPO-based 
FRIPS reagent conjugated AARAAACAA peptides, respectively. c) and d) FRIPS of 
AARAAACAA peptides prepared by Vazo 68 and TEMPO-based FRIPS reagents. Note that the 
TEMPO-based FRIPS reagent requires the less number of isolation and collisional activation 
steps for acquisition of FRIPS spectra than that of the Vazo 68 (MS4 for Vazo 68 versus MS3 for 
TEMPO-based FRIPS reagent). The N-terminal peptide fragment ions that contain the acetyl 
group at the N-termius are marked as Man, Mcn ions, respectively.
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Figure S5. FRIPS of doubly protonated Arg8-Conopressin G. a) CID of doubly protonated TE¬MPO-
based FRIPS conjugate of Arg8-Conopressin G at m/z 630 (MS2). b) CID of the acetyl radical containing 
Arg8-Conopressin G dication at m/z 552 (MS3). c) CID of the CH2S loss dication from the acetyl radical 
dication at m/z 529 (MS3). C=S could be thioaldehyde, thiomorpholin-3-one or thiirane products, G• is 
glycyl α-carbon radical, and “Ac-” is the acetylated N-terminal group except for the N-terminal 
thiomorpholin-3-one product case.  Superscripts (“N” and “C”) on the left side of the fragment ions 
indicate the position of the C=S residue that is located at the N-terminal or the C-terminal side of the 
peptide. Bold arrows indicate the precursor ions.
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Figure S6. FRIPS of doubly protonated TEMPO-CFIR/NCPR. a) CID of the A-chain, Ac-C=SFIR cation 
(even electron species) at m/z 578 (MS3), yielding the sequence of the A-chain. b) CID of the B-chain, 
NCS•PR cation (odd electron species) at m/z 488 (MS3). Losses of 44 (•CONH2, m/z 444) and 46 (CH2S, 
m/z 442) Da are prominent. c) CID of the B-chain cation at m/z 444 (even electron species, MS4). d) CID 
of the B-chain cation at m/z 442 (odd electron species, MS3). e) CID of the B-chain cation at m/z 487 
(even electron species, MS3). The CID spectra of various B-chain peptide cations (c, d, and e) allow 
sequencing of the B-chain. C=S is thioaldehyde, thiomorpholin-3-one or thiirane products, CS• is thiyl 
cysteine radical, G• is glycyl α-carbon radical, and “Ac-” is the acetylated N-terminal group except for the 
N-terminal thiomorpholin-3-one product case. Bold arrows indicate the precursor ions.
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Figure S7. FRIPS of insulin 4+ ion, m/z 1483 scanned by FT ICR. a) Full spectrum scanned 
from m/z 500 to 2500. b) The triply charged B-chain fragments, c) TEMPO loss and other 
neutral losses from the precursor 4+ ion, d) abundant backbone fragments between the doubly 
charged B-chain fragment and the protonated TEMPO loss ion, d) the singly charged A-chain 
fragments, and f) insulin backbone fragmentation summary in MS2. “Ac” is an acetyl group, “A” 
is the A-chain fragment, and “B” is the B-chain fragment. “AcAB-a243+” means the triply 
charged intact acetylated A-chain with a24 fragment of the B-chain. Most backbone fragments are 
observed the outside of the intermolecular disulfide bonds. Further sequencing was performed by 
isolating A- and B-chain fragments followed by additional collisional activation (Figure 8S). 
Note that the relative abundances in FT scan is biased by the charge state of the target ion so we 
put the ion trap spectra in the main text Figure 3 for fair comparison of disulfide bond cleavage 
yields with other model systems in this work (Compare the relative abundances of the singly 
charged A-chain fragments in FT ICR vs ion trap scans in the main text.)
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Figure S8. FRIPS of insulin 3+ ion, m/z 1978 scanned by FT ICR. a) Full spectrum scanned 
from m/z 500 to 2500. b) The doubly charged B-chain fragments, c) TEMPO loss and other 
neutral losses from the precursor 3+ ion with backbone fragments, d) the singly charged A-chain 
fragments, and e) insulin backbone fragmentation summary in MS2. Less backbone 
fragmentation was observed compared to that of the 4+ ion. As seen in the 4+ ion spectrum in 
Figure S6, most backbone fragments are observed the outside of the intermolecular disulfide 
bonds. 
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Figure S9. Insulin A and B chain sequence information obtained from MS3 following FRIPS of 
intact insulin. a) Relative abundances of product ions from CID of doubly charged insulin B 
chain ion (m/z 1699). b) Relative abundances of product ions from CID of triply charged insulin 
B chain ion (m/z 1134). c) Relative abundances of product ions from CID of singly charged 
insulin A chain ion (m/z 2335). The y-axis represents summed intensities of each ion type at a 
given location. Numbers in parentheses on x-axis give the residue number for a, b, c (first 
number) or y ions (second number).
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Table S1. Product ion assignment for FRIPS of 2HH and deviation from theoretical masses. 
Peak annotation Theoretical 
MS
FT MS FT 
ppm
IT MS IT 
ppm
B-chain CH2S loss from S• 728.3924 728.3933 1.24 728.5 85.3
B-chain =CH2 741.4002 741.4020 2.43 741.5 73.3
A-chain CH2S loss from S• 770.4030 770.4052 2.86 770.4 -51.1
B-chain =S 773.3723 773.3746 2.97 773.5 106.4
B-chain S• 774.3801 774.3803 0.30 774.5 96.2
B-chain S• 2nd isotope by 13C 775.3835 775.3851 2.02 775.5 91.6
A-chain =CH2 783.4108 783.4107 -0.18 783.5 55.9
Acetyl radical dication 794.8815 794.8803 -1.57 794.9 34.7
Acetyl radical dication 2nd isotope 795.3832 795.3826 -0.77 N/A N/A
Acetyl radical dication 3rd isotope 795.8848 795.8855 0.94 N/A N/A
2,2,6,6-tetramethylpiperidine loss 802.3750 802.3778 3.48 802.5 99.2
2,2,6,6-tetramethylpiperidine loss 
2nd isotope
802.8767 802.8780 1.62 N/A N/A
B-chain SS• 806.3522 806.3540 2.19 806.4 14.2
A-chain =S 815.3828 815.3851 2.76 815.5 88.0
A-chain S• 816.3907 816.3908 0.07 816.4 -33.1
A-chain SS• 848.3627 848.3615 -1.36 848.4 1.1
A-chain SS• 2nd isotope 849.3661 849.3678 1.98 N/A N/A
precursor ion 872.9509 872.9523 1.60 872.9 -47.9
avg ppm 1.69 62.7
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Figure S10. FRIPS MS3 (collisional activation of acetyl radical) of acetyl radical 3HH, 3DH, 
and 3HD, (a, b, and c) respectively. Highly selective C−S (m/z 741/743, 783/785, 806/808, and 
848/850) and S−S cleavage (m/z 773/775, 774/776, 815/817, 816/818) products are observed. 
See Figure 4c and Table 2 for the structures of the products. Almost no backbone fragmentation 
is observed, thus only the disulfide cleavage region is shown here. Loss of CH2S or CD2S from 
the thiyl radicals at m/z 816 (a-3HH and c-3HD) or 818 (b-3DH) yields the glycyl α-carbon 
radical product at m/z 770. Additional losses of HS•, HSS• and CH2S or CD2S complicate the 
correlation of product ion intensities to the distribution of C−S and S−S bond cleavages solely 
produced by an acetyl radical.
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Figure S11. a) ECD of the triply charged A-chain acetylated AARAAACAA disulfide-bridged 
dimer (5, m/z 530, bold arrow). The charge reduced doubly charged 
Ac−[AARAAACAA]−S−S−[AARAAACAA] (6, m/z 795) is generated by electron capture. 
Several ECD backbone fragments (c and z ions) are observed. b) Expansion of the m/z range in 
which disulfide cleavages occur. c) Scheme showing cleavage sites and fragment m/z values 
from each chain. 
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Figure S12. Collisional activation (MS3) of m/z 815 produced by disulfide bond cleavage of the 
AARAAACAA dimer using the FRIPS reagent. The observed product ions support a cyclic 
structure, with the most abundant product ions occurring at the C-terminal portion of the peptide 
not contained within the cyclic structure. Below the spectrum a possible mechanism for internal 
loss occurring within the cyclic ring is illustrated.
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Figure S13. Relative enthalpies of low energy conformers of N,N'-diacetyl-cystine-N-
methylamide at 298.15K and 1 atm. Geometry optimization and thermochemical calculation 
were performed using B3LYP/6-311++G(d,p) level of theory, and single point energy refinement 
was performed using B3LYP/6-311++G(3df,3pd) level of theory, B3LYP/6-311++G(3df,3pd)// 
B3LYP/6-311++G(d,p).
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Figure S14. a) Reaction energetics for S−S bond cleavage of N,N'-diacetyl-cystine-N-
methylamide by direct radical substitution at the β-carbon via front- or backside, showing 
relative enthalpies in kcal/mol. b) Schematic drawing of reaction mechanisms for direct radical 
substitution.
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Figure S15. The optimized transition state structure of hydrogen migration between α- and β-
carbons and reaction barriers from each side showing relative enthalpies in kcal/mol. 
In the mechanisms involving H-abstraction, the relative barriers for H-abstraction from the α- 
or β-carbons determine whether C−S or S−S bond cleavage subsequently occurs. From Figure 4, 
it is evident that H-abstraction reactions from the α- or β-carbons have only small differences in 
barriers and on this basis might both be expected to occur. However, H-abstraction by the N-
terminal acetyl radical group from the sterically more accessible β-carbons is likely to be 
favored. Therefore, the actual frequency of H-abstraction from the α-carbons may be low. To 
explain observed products possibly produced via the formation of the α-carbon radicals, we 
investigate the H-migration reaction between α- and β-carbons via a six membered ring transition 
state (Figure S15). If the barrier for the interchain H-migration between the α- and β-carbons is 
lower than that for subsequent β-cleavages of the resulting radicals generated by sterically 
favored H-abstraction from β-carbons, this migration can initiate various C−S or S−S bond 
dissociation pathways via a facile formation of the α-carbon radicals.
Figure S15 depicts the structure of the transition state for radical migration in which the 
transferred H-atom is approximately centered between the α- and β-carbons. The calculated 
reaction barrier from the β-carbon is rather high, ~20-23 kcal/mol but it is still 4-7 kcal/mol 
S21
lower than the overall endothermicity of S−S bond cleavage via the β-carbon radical. Therefore, 
it is energetically reasonable for the interchain H-atom migration to occur from the β-carbon to 
the α-carbon of a disulfide bond and the resulting α-carbon radical can undergo further C−S or 
S−S bond cleavages.
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